Australia’s share market, or the All Ordinaries Index (INDEXASX: XAO)(ASX: XAO), is currently up 0.35% at lunch.
The Telstra Corporation Ltd (ASX: TLS) share price is down 1.3%, with several blue chips hurting with the prospect of a US government budget shutdown.
Commonwealth Bank of Australia (ASX: CBA) shares are up 0.4% this morning despite revealing it is facing a number of additional costs for the current financial year.
The share price of funeral business Propel Funeral Partners Ltd (ASX: PFP) is up 0.8% because it announced a number of New Zealand based acquisitions.
Shares of pathology business Sonic Healthcare Limited (ASX: SHL) are in a trading halt due to the planned acquisition for $750 million in the US.
The Mayne Pharma Group Ltd (ASX: MYX) share price is up 2.8%, it received FDA approval of its Tolsura (SUBA itraconazole) 65mg capsules. The US anti-fungal triazole market has a value of around US$600 million, the clear unmet clinical need in serious systematic infections has an addressable market of around US$200 million according to Mayne.
Here are 3 stocks I own in April 2020...
Amidst the COVID-19 confusion, there are some companies still growing FAST (think: online meetings through Zoom, streaming companies like Netflix and eHealth services provided by Teledoc).
While the world grapples with COVID-19, some companies are still growing rapidly. The entire cloud computing market is valued around $US210 billion but if you ask me, it seems clear as day that this market is only going to get bigger in 2020 and beyond.
That's why our top investment analyst has just identified 3 growth stocks in a net cash position, with strong competitive forces... and obvious tailwinds at their back. He owns all three of them right now!
Claim a FREE investing report on our analyst's "3 best share ideas for the cloud revolution" when you create a free Rask Australia account.
Our report is 100% free and unlocks hundreds of hours of bonus content.
Disclaimer and warning: The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms of Service and Financial Services Guide before using this website.